HEADER    ANTIMICROBIAL PROTEIN                   23-JUN-22   8DFZ              
TITLE     NMR SHOWS WHY A SMALL CHEMICAL CHANGE ALMOST ABOLISHES THE            
TITLE    2 ANTIMICROBIAL ACTIVITY OF GCCF                                       
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: BACTERIOCIN GLYCOCIN F;                                    
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: GCCF;                                                       
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: LACTIPLANTIBACILLUS PLANTARUM;                  
SOURCE   3 ORGANISM_TAXID: 1590;                                                
SOURCE   4 GENE: GCCF;                                                          
SOURCE   5 EXPRESSION_SYSTEM: LACTIPLANTIBACILLUS PLANTARUM;                    
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 1590                                        
KEYWDS    GCCF, ANTIMICROBIAL, BACTERIOSTATIC, ANTIMICROBIAL PROTEIN            
EXPDTA    SOLUTION NMR                                                          
NUMMDL    10                                                                    
AUTHOR    E.HARJES,P.J.B.EDWARDS,G.NORRIS                                       
REVDAT   3   13-SEP-23 8DFZ    1       JRNL                                     
REVDAT   2   16-AUG-23 8DFZ    1       JRNL                                     
REVDAT   1   05-JUL-23 8DFZ    0                                                
JRNL        AUTH   E.HARJES,P.J.B.EDWARDS,S.W.BISSET,M.L.PATCHETT,G.B.JAMESON,  
JRNL        AUTH 2 S.H.YANG,C.D.NAVO,P.W.R.HARRIS,M.A.BRIMBLE,G.E.NORRIS        
JRNL        TITL   NMR SHOWS WHY A SMALL CHEMICAL CHANGE ALMOST ABOLISHES THE   
JRNL        TITL 2 ANTIMICROBIAL ACTIVITY OF GLYCOCIN F.                        
JRNL        REF    BIOCHEMISTRY                  V.  62  2669 2023              
JRNL        REFN                   ISSN 0006-2960                               
JRNL        PMID   37531216                                                     
JRNL        DOI    10.1021/ACS.BIOCHEM.3C00197                                  
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : YASARA                                               
REMARK   3   AUTHORS     : ELMER KRIEGER                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 8DFZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUN-22.                  
REMARK 100 THE DEPOSITION ID IS D_1000266548.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 307                                
REMARK 210  PH                             : 0                                  
REMARK 210  IONIC STRENGTH                 : 0                                  
REMARK 210  PRESSURE                       : 1 ATM                              
REMARK 210  SAMPLE CONTENTS                : 1 MM NATURAL ABUNDABNCE GCCF       
REMARK 210                                   MODIFIED, 95% H2O/5% D2O           
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : TOCSY; 2D 1H-1H NOESY; 2D DQF      
REMARK 210                                   -COSY; 2D 1H-13C HSQC; HMBC; 3D    
REMARK 210                                   1H-13C TOCSY                       
REMARK 210  SPECTROMETER FIELD STRENGTH    : 700 MHZ                            
REMARK 210  SPECTROMETER MODEL             : BRUKER AVANCE                      
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : YASARA, CARA, ATNOS                
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 30                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 10                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500  1 MET A  24   N   -  CA  -  CB  ANGL. DEV. = -11.5 DEGREES          
REMARK 500  3 MET A  24   N   -  CA  -  CB  ANGL. DEV. = -10.9 DEGREES          
REMARK 500  6 MET A  24   N   -  CA  -  CB  ANGL. DEV. = -10.9 DEGREES          
REMARK 500  7 MET A  24   N   -  CA  -  CB  ANGL. DEV. = -11.2 DEGREES          
REMARK 500 10 MET A  24   N   -  CA  -  CB  ANGL. DEV. = -11.0 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 ASP A  17      -95.87     24.82                                   
REMARK 500  1 THR A  20      -62.01   -105.48                                   
REMARK 500  1 HIS A  33       70.34   -118.19                                   
REMARK 500  1 SER A  40       51.67   -117.17                                   
REMARK 500  1 HIS A  42       32.27   -151.67                                   
REMARK 500  2 ASP A  17      -89.98     22.23                                   
REMARK 500  2 THR A  20      -61.87   -101.49                                   
REMARK 500  2 HIS A  34       22.18   -151.07                                   
REMARK 500  2 SER A  39       29.47   -151.85                                   
REMARK 500  2 TYR A  41      -69.54     61.17                                   
REMARK 500  2 HIS A  42       24.09   -141.11                                   
REMARK 500  3 ASP A  17      -86.67     31.34                                   
REMARK 500  3 THR A  20      -62.30   -103.25                                   
REMARK 500  3 HIS A  34       17.79   -153.94                                   
REMARK 500  3 TYR A  41      -33.06     65.04                                   
REMARK 500  4 ASP A  17      -88.99     23.78                                   
REMARK 500  4 THR A  20      -62.06   -101.50                                   
REMARK 500  4 TYR A  41      -51.66     65.79                                   
REMARK 500  4 HIS A  42       19.01   -142.48                                   
REMARK 500  5 ASP A  17      -87.85     36.46                                   
REMARK 500  5 THR A  20      -62.30   -102.75                                   
REMARK 500  5 HIS A  34       42.96   -149.40                                   
REMARK 500  5 SER A  40       48.80    -73.96                                   
REMARK 500  6 ASP A  17      -88.43     33.32                                   
REMARK 500  6 THR A  20      -61.99   -102.84                                   
REMARK 500  6 SER A  36     -161.72     58.27                                   
REMARK 500  6 SER A  39       18.20     55.34                                   
REMARK 500  6 TYR A  41       21.21    -73.01                                   
REMARK 500  6 HIS A  42       25.14   -141.82                                   
REMARK 500  7 ASP A  17      -93.59     36.68                                   
REMARK 500  7 THR A  20      -62.29   -102.91                                   
REMARK 500  7 HIS A  34       40.40   -150.34                                   
REMARK 500  7 SER A  38      156.01     70.88                                   
REMARK 500  7 SER A  39        6.95     59.09                                   
REMARK 500  7 HIS A  42       22.53   -144.56                                   
REMARK 500  8 ASP A  17      -88.81     23.85                                   
REMARK 500  8 THR A  20      -62.24   -101.21                                   
REMARK 500  8 HIS A  33       52.54   -109.96                                   
REMARK 500  8 HIS A  42       19.44   -151.93                                   
REMARK 500  9 ASP A  17      -89.69     21.86                                   
REMARK 500  9 THR A  20      -62.31   -100.98                                   
REMARK 500  9 HIS A  33       77.39   -119.24                                   
REMARK 500  9 HIS A  34       40.13   -151.74                                   
REMARK 500  9 HIS A  42       20.74   -146.85                                   
REMARK 500 10 ASP A  17      -89.25     23.22                                   
REMARK 500 10 THR A  20      -62.45   -102.15                                   
REMARK 500 10 HIS A  34       39.24   -153.35                                   
REMARK 500 10 HIS A  42       31.15   -160.52                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2KUY   RELATED DB: PDB                                   
REMARK 900 SAME PEPTIDE WITHOUT SER 18 MODIFICATION                             
REMARK 900 RELATED ID: 31028   RELATED DB: BMRB                                 
REMARK 900 NMR SHOWS WHY A SMALL CHEMICAL CHANGE ALMOST ABOLISHES THE           
REMARK 900 ANTIMICROBIAL ACTIVITY OF GCCF                                       
DBREF  8DFZ A    1    43  UNP    E9K9Z1   GCCF_LACPN      22     64             
SEQRES   1 A   43  LYS PRO ALA TRP CYS TRP TYR THR LEU ALA MET CYS GLY          
SEQRES   2 A   43  ALA GLY TYR ASP EW6 GLY THR CYS ASP TYR MET TYR SER          
SEQRES   3 A   43  HIS CYS PHE GLY ILE LYS HIS HIS SER SER GLY SER SER          
SEQRES   4 A   43  SER TYR HIS CYS                                              
MODRES 8DFZ EW6 A   18  SER  MODIFIED RESIDUE                                   
HET    EW6  A  18      13                                                       
HET    NAG  A 101      28                                                       
HET    NAG  A 102      28                                                       
HETNAM     EW6 ALPHA-METHYL-L-SERINE                                            
HETNAM     NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE                         
HETSYN     EW6 (2S)-2-AZANYL-2-METHYL-3-OXIDANYL-PROPANOIC ACID                 
HETSYN     NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-           
HETSYN   2 NAG  D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-          
HETSYN   3 NAG  2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE                         
FORMUL   1  EW6    C4 H9 N O3                                                   
FORMUL   2  NAG    2(C8 H15 N O6)                                               
HELIX    1 AA1 PRO A    2  CYS A   12  1                                  11    
HELIX    2 AA2 GLY A   13  GLY A   15  5                                   3    
HELIX    3 AA3 THR A   20  PHE A   29  1                                  10    
SSBOND   1 CYS A    5    CYS A   28                          1555   1555  2.02  
SSBOND   2 CYS A   12    CYS A   21                          1555   1555  2.02  
LINK         C   ASP A  17                 N   EW6 A  18     1555   1555  1.38  
LINK         C   EW6 A  18                 N   GLY A  19     1555   1555  1.34  
LINK         OG  EW6 A  18                 C1  NAG A 101     1555   1555  1.46  
LINK         SG  CYS A  43                 C1  NAG A 102     1555   1555  1.87  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1                      
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1